The use of postoperative radiation after nipple sparing mastectomy.

Nipple-sparing mastectomy (NSM) is a surgical procedure designed to reduce the disabling psychological effects of radical mastectomy. The preservation of the nipple-areola complex (NAC) produces a better result of the breast reconstruction, but some concerns exist of increasing the risk for local recurrence (LR). To reduce this risk a restricted inclusion criteria is suggested. In case of patients with high or intermediate risk the use of radiation therapy (RT) is also recommended, but a current standard for radiation after NSM is not available. In the literature, with few exceptions, there are few reports detailing indication and technique of radiation after NSM. There is a general consensus that post-mastectomy radiation therapy (PMRT) should be considered for patients with four or more positive axillary lymph nodes, primary tumour size 5 cm or more, T4 disease for skin involvement and positive margin. Almost all of these patients are candidate to receive external beam radiotherapy to the chest wall and to the supraclavicular/axillary region, less to the internal mammary chain. PMRT could be omitted in elderly patients with poor clinical conditions or co-morbidities that substantially reduce the life expectancy. Because the indications of NSM have been progressively extended also to larger or multi-centric tumours, this procedure has been criticised because of the increased risk of recurrence behind the areola due to the remaining glandular tissue, especially the terminal ducts, kept to preserve its blood supply, and especially in case of more advanced tumours. To reduce this concern, adjuvant RT after NSM should be administered in high risk patients who meet the criteria for current recommendations, but in other cases, such as in patients with intermediate risk or lower stage, the indication should be discussed on individual.

[1]  Barbara L. Smith,et al.  Nipple-Sparing Mastectomy in Irradiated Breasts: Selecting Patients to Minimize Complications , 2015, Annals of Surgical Oncology.

[2]  Laurence Collette,et al.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. , 2015, The New England journal of medicine.

[3]  D. Rades,et al.  Nipple-sparing mastectomy in breast cancer patients: The role of adjuvant radiotherapy (Review). , 2015, Oncology letters.

[4]  R. Gelber,et al.  Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  D. Winchester,et al.  Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1–T2 and One to Three Positive Lymph Nodes , 2015, Annals of Surgical Oncology.

[6]  T. Whelan,et al.  Regional Nodal Irradiation in Early-Stage Breast Cancer. , 2015, The New England journal of medicine.

[7]  EBCTCG (Early Breast Cancer Trialists' Collaborati Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[8]  R. Souchon,et al.  DEGRO practical guidelines for radiotherapy of breast cancer IV , 2014, Strahlentherapie und Onkologie.

[9]  B. Haffty Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials: EBCTCG (Early Breast Cancer Trialists' Collaborative Group) () Lancet 383:2127-2135, 2014§ , 2014 .

[10]  Shailesh Agarwal,et al.  Radiation Delivery in Patients Undergoing Therapeutic Nipple-Sparing Mastectomy , 2014, Annals of Surgical Oncology.

[11]  A. Luini,et al.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. , 2013, The Lancet. Oncology.

[12]  Phoebe E. Freer,et al.  Increasing Eligibility for Nipple-Sparing Mastectomy , 2013, Annals of Surgical Oncology.

[13]  A. Luini,et al.  Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  G. Curigliano,et al.  Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  G. Curigliano,et al.  Risk of Locoregional Recurrence in Patients With False-Negative Frozen Section or Close Margins of Retroareolar Specimen in Nipple-Sparing Mastectomy , 2012, Annals of Surgical Oncology.

[16]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[17]  G. Curigliano,et al.  Nipple-sparing mastectomy—is it worth the risk? , 2011, Nature Reviews Clinical Oncology.

[18]  G. Sgourakis,et al.  Comparison of Skin-Sparing Mastectomy Versus Non–Skin-Sparing Mastectomy for Breast Cancer: A Meta-Analysis of Observational Studies , 2010, Annals of surgery.

[19]  N. Rowell Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  A. Luini,et al.  Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO) , 2009, Breast Cancer Research and Treatment.

[21]  K. Benediktsson,et al.  Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  J. Overgaard,et al.  Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.